Penclomedine in Treating Patients With Solid Tumors or Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of penclomedine in treating patients with malignant
solid tumors or lymphomas. Drugs used in chemotherapy use different ways to stop tumor cells
from dividing so they stop growing or die.